Provider review, September 2026
Raeliva publishes a standing monthly price for nine separate products and warns its own readers that the monthly figure shown on a multi-month plan is an effective rate rather than a payment — a disclosure almost no seller volunteers. It names no dispensing pharmacy, and it says lab work may be billed separately on top of the plan price.
Raeliva is not a paid partner; this link may earn a commission if that changes. Full disclosure.
Its own sentence: "The monthly figure we show for a multi-month plan is the effective rate … not a monthly payment."
That is the exact device most sellers use to make a headline look small, and this one names it in writing.
Every as-low-as hero figure on the site was declined here on the strength of that sentence, and the standing monthly plan was filed instead. What is recorded is what a reader pays each month without prepaying anything.
Both weight-loss molecules are priced twice — as an injection and as an orally disintegrating tablet — and again as microdose products, which are priced separately from the full-dose lanes and carry no prepaid alternative.
NAD+, sermorelin and glutathione each carry their own monthly plan, with glutathione offering only that one plan.
Where a prepaid alternative exists, the seller states it as a total for a stated number of months rather than dressing it up as a monthly rate.
It states twice that "The Services are currently available to individuals located in all 50 U.S. states" and that "We ship to all 50 states. Providers in our network are licensed in every US state."
That is a claim, and it is explicit, but it is a count rather than an enumeration. No state list is published, so there is nothing to check row by row.
It names no dispensing pharmacy anywhere on the site, which leaves the other half of the fulfilment chain unstated as well.
Its legal entity carries the word research in its name. That is not a research-use signal: this is a prescriber-gated telehealth platform with no research-use language anywhere on it. Read the sentences, not the corporate name.
Its rubric does not credit labs, and the seller is the source of that: "Lab work, when required, may be billed separately unless otherwise stated."
It also states plainly that "The FDA does not review or approve compounded medications for safety or effectiveness," and that compounded medicines are not the same as brand-name products. Both are quoted here, not endorsed.
Trellis Vitality frames its program around body-composition tracking rather than scale weight, pairing NAD+, glutathione and tesamorelin with at-home biomarker panels and a 90-day re-test, and names its dispensing pharmacy, VialsRX in Houston, by address.
Read the full Trellis Vitality review
Trellis Vitality is not a paid partner; this link may earn a commission if that changes. Full disclosure.
Visit Trellis VitalityNot on a multi-month plan. The seller states outright that the monthly figure shown on those plans is an effective rate, not a payment. The standing monthly plan is what is recorded here.
It says so twice, and says its network providers are licensed in every state. It publishes no state list, so this is recorded as the seller's claim rather than as a verified list.
No. Its own terms say lab work, when required, may be billed separately unless otherwise stated.
No. Its legal name contains the word research, but the platform is prescriber-gated and carries no research-use language anywhere.
Raeliva is not a paid partner; this link may earn a commission if that changes. Full disclosure.